Professional Documents
Culture Documents
1) Ask the patient about the presence of pain Opioid Equianalgesic Chart
2) Perform a comprehensive pain assessment, including: Onset, Opioid IV/SQ mg route PO/PR mg route Duration of Effect
duration, location; Intensity; Quality; Aggravating/Alleviating Morphine 5 15 3-4 hours
factors; Effect on function, QOL; Patients goal; Response to prior
treatment; H & P. Long Acting 15 8-12 hours
3) Avoid IM route, if possible Morphine
4) Treat persistent pain with scheduled medications Oxycodone 10 3-4 hours
5) Ordinarily 2 drugs of the same class (e.g. NSAIDS) should not be Long Acting 10 8-12 hours
given concurrently; however 1 long-acting and 1 short-acting opioid Oxycodone
may be prescribed concomitantly. Hydromorphone 0.75 4 3-4 hours
6) Short-acting strong opiates (morphine, hydromorphone, Meperidine** 50 150 2-3 hours
oxycodone) should be used to treat moderate to severe pain. Long- Codeine 50 100 3-4 hours
acting strong opiates (e.g. Oxycontin, MS Contin, Fentanyl patch) Hydrocodone 15 3-4 hours
should be started once pain is controlled on short-acting
Fentanyl Transdermal Patch
preparations. Never start an opioid naïve patient on long-acting
Opioid doses equivalent to 25mcg/hr fentanyl patch
medications.
Drug Oral IV
7) Titrate the opiate dose upward if pain is worsening or inadequately
controlled: Increase dose by 25- 50% for mild/moderate pain; Morphine 45mg/24hr 15mg/24hr
Increase by 50-100% for mod/severe pain. Hydromorphone 10mg/24hr 2mg/24hr
8) Manage breakthrough pain with short-acting opiates. Dose should Patch duration: 48-72 hours
be 10% of total daily dose. Breakthrough doses can be given as often Onset of effect: 12-24 hours before full analgesic effect of patch occurs
as Q 60min if PO; Q 30min if SQ; Q 15min if IV. (As long a patient Must prescribe Short acting opioid for breakthrough pain
has normal renal/hepatic function) Opioids use for Liver or Renal Failure
9) When converting patient from one opioid to another, decrease the Recommended Use with caution
dose of the second opioid by 25-50% to correct for incomplete cross- Hydromorphone Codeine *
tolerance. Fentanyl Morphine *
10) Manage opioid side effects aggressively. Constipation should be Oxycodone *
treated prophylactically. * These opioid have active metabolites that are renally eliminated
** Meperidine is not recommended b/c the metabolite, normeperidine, may
accumulate in patients with poor renal functions causing CNS toxicity. Meperidine
is contraindicated w/ MAOI’s